Compliant Analysis of Patient Samples and Data

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorSequenom, Inc.

About this trial

Patients of scientific interest who have provided a commercial sample to LabCorp or one of its' affiliates will have their de-identified remnant samples and/or data used for research and development. Other commercial patients will be followed up on after informed consent is obtained.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Arm 1

All samples and data are de-identified and HIPAA compliant

Arm 2

Subject is of scientific interest to the Sponsor or treating physician

Disqualifiers

Arm 1

Subject is from a US state or a country where local law restricts the use of de-identified data and/or remnants of specimens for research and/or development

Arm 2

Any medical or mental condition that would interfere with the subjects' ability to willingly give written informed consent

Trial population

Arm 1 - Female or male patient samples submitted to Sequenom or LabCorp affiliate for routine clinical care testing that no longer need to be maintained for clinical purposes. Arm 2 - Female or male subjects of scientific interest who have provided written informed consent/assent.

Trial design

Design model

Cohort

Time perspective

Other

Treatments tested in this trial

  • Multiple interventions depending on diagnostic test being run.

    Device

    Remnant samples and corresponding data from multiple diagnostic tests will be stored for future research and development.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Remnant samples and data for research and development

Remnant samples and data for research and development

Time frame
Retrospective and Prospective collection. Samples and data may be collected for up 12 months after enrollment.
2

Sample and data collection from subjects of scientific interest

Collect additional clinical data and samples if needed from subjects tested by LabCorp or an affiliate.

Time frame
Prospective collection. Samples and data may be collected for up to 12 months after enrollment

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sequenom, Inc.

Lead sponsor

Laboratory Corporation of America

Collaborator